Role of H(2 )receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a global pandemic putting the population at a high risk of infection-related health hazards, mortality and a potential failure of proper medical therapies. Therefore, it is necessary to evaluate the potential use of the existing drugs that could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohiuddin Chowdhury, Abu Taiub Mohammed, Kamal, Aktar, Abbas, Md Kafil Uddin, Karim, Md Rezaul, Ali, Md Ahsan, Talukder, Shubhashis, Hamidullah Mehedi, H M, Hassan, Hamid, Shahin, Abul Hossain, Li, Yarui, He, Shuixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403664/
https://www.ncbi.nlm.nih.gov/pubmed/36159508
http://dx.doi.org/10.12998/wjcc.v10.i23.8170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403664/
https://www.ncbi.nlm.nih.gov/pubmed/36159508
http://dx.doi.org/10.12998/wjcc.v10.i23.8170

Ejemplares similares